Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide
- PMID: 3080477
- PMCID: PMC423370
- DOI: 10.1172/JCI112328
Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide
Abstract
We analyzed high molecular weight polysaccharide (PS) from the Fisher immunotype 2 (IT-2) strain of Pseudomonas aeruginosa for molecular composition and structure, then determined its immunogenicity in healthy adults. The PS was composed of 2-acetamido-2,6-dideoxygalactose (N-acetyl fucosamine) and glucose in a molar ratio of 2:1. Structural analysis by carbon-13 and proton nuclear magnetic resonance confirmed that the high molecular weight PS was structurally identical to that of the O-specific side chain of the lipopolysaccharide. PS differed from this material in molecular size. Immunization of 19 adult volunteers with doses of 50-100 micrograms of PS resulted in significant rises (P less than 0.04-P less than 0.0001) in binding antibody levels and killing antibody titers 2 and 4 wk postimmunization. The only reaction to the vaccine was localized tenderness at the immunization site. Analysis of the immunoglobulin isotype response to the vaccine showed a rise in specific serum IgG and IgA antibodies. Heterologous responses to other P. aeruginosa PS antigens were not seen. The antibody levels attained by vaccination were comparable with those in acute-phase serum samples of patients who survived sepsis with IT-2 P. aeruginosa and were significantly higher (P less than 0.03) than specific antibody levels in bacteremic patients who died. These results confirm that PS is a high molecular weight, immunogenic form of the P. aeruginosa IT-2 serotype antigen, eliciting levels of type-specific antibody comparable with those seen among patients surviving an episode of P. aeruginosa sepsis.
Similar articles
-
High-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2.Infect Immun. 1981 Nov;34(2):461-8. doi: 10.1128/iai.34.2.461-468.1981. Infect Immun. 1981. PMID: 6171520 Free PMC article.
-
Immunochemical characterization of high-molecular-weight polysaccharide from Fisher immunotype 3 Pseudomonas aeruginosa.Infect Immun. 1984 Aug;45(2):309-13. doi: 10.1128/iai.45.2.309-313.1984. Infect Immun. 1984. PMID: 6430805 Free PMC article.
-
Immunochemistry of Pseudomonas aeruginosa lipopolysaccharides and high-molecular-weight polysaccharides.Rev Infect Dis. 1983 Nov-Dec;5 Suppl 5:S950-6. doi: 10.1093/clinids/5.supplement_5.s950. Rev Infect Dis. 1983. PMID: 6197738
-
Isolation, structure, and immunogenicity of Pseudomonas aeruginosa immunotype 4 high-molecular-weight polysaccharide.Infect Immun. 1989 Feb;57(2):426-31. doi: 10.1128/iai.57.2.426-431.1989. Infect Immun. 1989. PMID: 2492260 Free PMC article.
-
Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa.J Clin Invest. 1982 Feb;69(2):303-8. doi: 10.1172/jci110453. J Clin Invest. 1982. PMID: 6799548 Free PMC article.
Cited by
-
Increased elastase secretion by peripheral blood monocytes in cystic fibrosis patients.Clin Exp Immunol. 1990 Jun;80(3):344-9. doi: 10.1111/j.1365-2249.1990.tb03290.x. Clin Exp Immunol. 1990. PMID: 2142640 Free PMC article.
-
Pseudomonas aeruginosa-induced lung and pleural injury in sheep. Differential protective effect of circulating versus alveolar immunoglobulin G antibody.J Clin Invest. 1993 Sep;92(3):1221-8. doi: 10.1172/JCI116693. J Clin Invest. 1993. PMID: 8376581 Free PMC article.
-
Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06.Infect Immun. 1994 Apr;62(4):1137-43. doi: 10.1128/iai.62.4.1137-1143.1994. Infect Immun. 1994. PMID: 8132318 Free PMC article.
-
In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide.Infect Immun. 1989 Jan;57(1):174-9. doi: 10.1128/iai.57.1.174-179.1989. Infect Immun. 1989. PMID: 2491835 Free PMC article.
-
Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.J Clin Invest. 1987 Jul;80(1):51-6. doi: 10.1172/JCI113062. J Clin Invest. 1987. PMID: 3110215 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous